Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kardiatonos

2015 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$25K LATEST DEAL AMOUNT
Description

Developer of therapeutics. The company specializes in developing therapeutics and diagnostics for cardiovascular diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Primary Office
  • 4909 South Lapeer Road
  • Metamora, MI 48455
  • United States

+1 (248) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kardiatonos’s full profile, request a free trial.

Kardiatonos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 23-Nov-2015 $25K 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Kardiatonos Executive Team (3)

Name Title Board
Seat
Contact
Info
Kenneth Kohn JD Chief Executive Officer & Board Member
Nicholas Cocco President & Board Member
Josephino Tunac Executive Officer & Board Member

Kardiatonos Board Members (3)

Name Representing Role Since Contact
Info
Josephino Tunac Kardiatonos Executive Officer & Board Member 000 0000
Kenneth Kohn JD Kardiatonos Chief Executive Officer & Board Member 000 0000
Nicholas Cocco Kardiatonos President & Board Member 000 0000